Effects of Substitutions at the 4′ and 2 Positions on the Bioactivity of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Substitutions at the 4′ and 2 Positions on the Bioactivity of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 57, Issue 12, Pages 6254-6264
Publisher
American Society for Microbiology
Online
2013-10-08
DOI
10.1128/aac.01703-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA
- (2013) Eleftherios Michailidis et al. Retrovirology
- HIV-1 Antiretroviral Drug Therapy
- (2013) E. J. Arts et al. Cold Spring Harbor Perspectives in Medicine
- Response of Simian Immunodeficiency Virus to the Novel Nucleoside Reverse Transcriptase Inhibitor 4′-Ethynyl-2-Fluoro-2′-DeoxyadenosineIn VitroandIn Vivo
- (2012) Michael Murphey-Corb et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and biological evaluation of a series of thieno-expanded tricyclic purine 2′-deoxy nucleoside analogues
- (2012) Orrette R. Wauchope et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Antiviral therapies: Focus on hepatitis B reverse transcriptase
- (2012) Eleftherios Michailidis et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- 4′-C-Methyl-2′-Deoxyadenosine and 4′-C-Ethyl-2′-Deoxyadenosine Inhibit HIV-1 Replication
- (2011) B. Christie Vu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Interaction of Human Mitochondrial DNA Polymerase γ with the Novel Nucleoside Reverse Transcriptase Inhibitor 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine Indicates a Low Potential for Host Toxicity
- (2011) Christal D. Sohl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tricyclic 2′-C-Modified Nucleosides as Potential Anti-HCV Therapeutics
- (2010) Orrette R. Wauchope et al. ORGANIC LETTERS
- Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase
- (2010) Kamalendra Singh et al. Viruses-Basel
- Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action
- (2009) Caroline Bazzoli et al. CLINICAL PHARMACOKINETICS
- Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4′-Ethynyl-2-fluoro-2′-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor
- (2009) Eleftherios Michailidis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HCV drug discovery aimed at viral eradication
- (2009) R. F. Schinazi et al. JOURNAL OF VIRAL HEPATITIS
- Contrasting Behavior of Conformationally Locked Carbocyclic Nucleosides of Adenosine and Cytidine as Substrates for Deaminases
- (2009) Victor E. Marquez et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- 2′-Deoxy-4′-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants
- (2008) Atsushi Kawamoto et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition
- (2008) Stefan G. Sarafianos et al. JOURNAL OF MOLECULAR BIOLOGY
- Fluorine Substituted Adenosines As Probes of Nucleobase Protonation in Functional RNAs
- (2008) Ian T. Suydam et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase
- (2008) Luis Menéndez-Arias VIRUS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started